Clinical trial
Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review
NCT07307157 is registered in ClinicalTrials.gov with Harvard Medical School (HMS and HSDM) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Head-to-Head Evaluation of the Cancer Ontology Supervised Multimodal Orchestration (COSMO) AI System Versus Pathologist-Only Review
- Lead sponsor
- Harvard Medical School (HMS and HSDM)
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- June 12, 2025
- Completion date
- January 31, 2026
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
brain cancer, lung cancer (diagnosis), renal cancer